Evidence map›Paper›PMID 33415401›Full record

ArticleParasitology research2021

Proteomic analysis reveals differentially abundant proteins probably involved in the virulence of amastigote and promastigote forms of Leishmania infantum.

Luiz Fialho Junior, Simone da Fonseca Pires, Richard Burchmore, Suzanne McGill, Stefan Weidt, Jeronimo Conceição Ruiz, Frederico Goncalves Guimarães, Alexander Chapeourouge, Jonas Perales, Hélida Monteiro de Andrade

Abstract read
PubMed Publisher
In one paragraph

Article in Parasitology research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Characterization of Differentially Abundant Proteins AmongFrontiers in cellular and infection microbiology · 2022
    Article
  5. Challenges and Tools for In VitroPathogens (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Luiz Fialho JuniorLaboratório de Leishmanioses, Departamento de Parasitologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, CEP: 31270-901, Brazil.
Simone da Fonseca PiresLaboratório de Leishmanioses, Departamento de Parasitologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, CEP: 31270-901, Brazil.
Richard BurchmoreGlasgow Polyomics, College of Medical, Veterinary and Life Sciences, University of Glasgow, Garscube Campus, Glasgow, Scotland, G12 1QH, UK.
Suzanne McGillGlasgow Polyomics, College of Medical, Veterinary and Life Sciences, University of Glasgow, Garscube Campus, Glasgow, Scotland, G12 1QH, UK.
Stefan WeidtGlasgow Polyomics, College of Medical, Veterinary and Life Sciences, University of Glasgow, Garscube Campus, Glasgow, Scotland, G12 1QH, UK.
Jeronimo Conceição RuizGrupo Informática de Biossistemas e Genômica, Programa de Pós- Graduação em Ciências da Saúde, Instituto René Rachou, Fiocruz Minas, Belo Horizonte, Minas Gerais, Brazil.
Frederico Goncalves GuimarãesGrupo Informática de Biossistemas e Genômica, Programa de Pós- Graduação em Ciências da Saúde, Instituto René Rachou, Fiocruz Minas, Belo Horizonte, Minas Gerais, Brazil.
Alexander ChapeourougeLaboratório de Toxinologia, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, RJ, CEP: 21040-360, Brazil.
Jonas PeralesLaboratório de Toxinologia, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, RJ, CEP: 21040-360, Brazil.
Hélida Monteiro de AndradeLaboratório de Leishmanioses, Departamento de Parasitologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, CEP: 31270-901, Brazil. helidandrade@gmail.com.ORCID http://orcid.org/0000-0003-2823-4530
Universidade Federal de Minas Gerais · BRUniversity of Glasgow · GBFundação Oswaldo Cruz · BR

Funding

CNPq CNPq-573547FAPEMIG PPM00129-17
6 · The paper itself

Abstract

Owing to the importance and clinical diversity of Leishmania infantum, studying its virulence factors is promising for understanding the relationship between parasites and hosts. In the present study, differentially abundant proteins from strains with different degrees of virulence in promastigote and amastigote forms were compared using two quantitative proteomics techniques, differential gel electrophoresis and isobaric mass tag labeling, followed by identification by mass spectrometry. A total of 142 proteins were identified: 96 upregulated and 46 downregulated proteins in the most virulent strain compared to less virulent. The interaction between the proteins identified in each evolutionary form was predicted. The results showed that in the amastigote form of the most virulent strain, there was a large group of proteins related to glycolysis, heat shock, and ribosomal proteins, whereas in the promastigote form, the group consisted of stress response, heat shock, and ribosomal proteins. In addition, biological processes related to metabolic pathways, ribosomes, and oxidative phosphorylation were enriched in the most virulent strain (BH400). Finally, we noted several proteins previously found to play important roles in L. infantum infection, which showed increased abundance in the virulent strain, such as ribosomal proteins, HSP70, enolase, fructose 1,6-biphosphate aldolase, peroxidoxin, and tryparedoxin peroxidase, many of which interact with each other.

Indexed as

AnimalsLeishmania infantumLife Cycle StagesProteomeProteomicsProtozoan ProteinsVirulenceVirulence FactorsProteomeProtozoan ProteinsVirulence FactorsDIGELeishmania infantumProteomeTMTVirulence

Identifiers

PMID33415401
OpenAlexW3119706506

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.